News and analysis for the well-informed compliance or audit exec. Select an option and click continue.
Annual Membership $499 Value offer
Full price one year membership with auto-renewal.
Membership $599
One-year only, no auto-renewal.
- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
By Jeff Dale2023-09-14T16:09:00
A Texas-based dermatology management company agreed to pay nearly $8.9 million to settle allegations by the Department of Justice (DOJ) regarding apparent violations of the False Claims Act.
The settlement total agreed to by Oliver Street Dermatology Management, doing business as U.S. Dermatology Partners (USDP), includes approximately $5.9 million in restitution, U.S. Attorney for the Northern District of Texas Leigha Simonton announced in a press release Wednesday.
Between January 2013 and July 2018, USDP acquired multiple dermatology practices across the United States. In September 2021, the company voluntarily self-disclosed to the DOJ credible evidence that former senior managers offered or agreed to increase the purchase price of 11 acquired dermatology practices in exchange for referrals to USDP-affiliated entities following the acquisition, the DOJ alleged. Claims for some of those services were later submitted to Medicare for payment, the DOJ found.
THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.
News and analysis for the well-informed compliance or audit exec. Select an option and click continue.
Annual Membership $499 Value offer
Full price one year membership with auto-renewal.
Membership $599
One-year only, no auto-renewal.
2023-11-13T20:15:00Z By Adrianne Appel
New guidance from the Department of Health and Human Services is designed to apply generally to the healthcare industry, from doctors to pharmaceutical manufacturers, and help all such entities self-monitor their compliance and prevent waste, fraud, and abuse.
2023-10-31T18:18:00Z By Kyle Brasseur
Pharmaceuticals firm Nostrum Laboratories and its founder and chief executive officer could pay up to $50 million as part of a settlement with the Department of Justice addressing alleged violations of the False Claims Act by underpaying Medicaid rebates.
2023-10-11T19:34:00Z By Jeff Dale
Cardiac Imaging and its chief executive agreed to pay a total of more than $85 million to settle charges levied by the Department of Justice addressing alleged violations of the False Claims Act regarding unlawful kickbacks.
2024-10-22T21:18:00Z By Adrianne Appel
Precision Toxicology has agreed to pay $27 million to settle allegations first brought by whistleblowers in three cases, that the company billed the federal government for unnecessary drug tests and paid kickbacks to doctors, the Department of Justice (DOJ) said.
2024-10-22T16:08:00Z By Aaron Nicodemus
Fund management company WisdomTree will pay $4 million to settle allegations by the Securities and Exchange Commission that it improperly invested in fossil fuel and tobacco companies in environmental, social and governance (ESG) funds despite promising to avoid them.
2024-10-18T18:10:00Z By Adrianne Appel
A Vietnamese alcohol company has agreed to pay $860,000 to settle allegations by the Office of Foreign Assets Control (OFAC) that its business with North Korea involved U.S. financial institutions.
Site powered by Webvision Cloud